General Information of the Compound
| Compound ID |
CP0380810
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3-{(1R,2S,3R)-3-Hydroxy-2-[(E)-(S)-3-hydroxy-4-(2-methoxy-phenyl)-but-1-enyl]-5-oxo-cyclopentylsulfanyl}-propylsulfanyl)-acetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H28O6S2
|
||||||||||||||||||
| Molecular Weight |
440.583
|
||||||||||||||||||
| Canonical SMILES |
COc1ccccc1C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1SCCCSCC(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H28O6S2/c1-27-19-6-3-2-5-14(19)11-15(22)7-8-16-17(23)12-18(24)21(16)29-10-4-9-28-13-20(25)26/h2-3,5-8,15-17,21-23H,4,9-13H2,1H3,(H,25,26)/b8-7+/t15-,16+,17-,21-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UFVYMWZFQCQLEP-KNBXEBOLSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02279, Prostacyclin receptor
Protein ID: PT02988, Prostaglandin E2 receptor EP1 subtype
Protein ID: PT02989, Prostaglandin E2 receptor EP2 subtype
Protein ID: PT02345, Prostaglandin E2 receptor EP3 subtype
Protein ID: PT02346, Prostaglandin E2 receptor EP4 subtype